Suad Hannawi, BhSc; MD; MRCP (UK), FRCP (UK); MIPH (AUS), PHD (AUS), is a Consultant of Rheumatology at the Ministry of Health and Prevention (MOHAP) of UAE. She is also the Chairman of Rheumatology in the MOHAP, Deputy Chair of the Central Research Ethic Committee (REC), Chairman of Dubai Health District REC, and a representative of the United Arab Emirates in the Gulf Cooperation Countries (GCC) Medical Research Committee and in the UNESCO Science Ethics Regulations initiative.
After receiving her Bachelor of Science (BhSc), and the Medical Diploma (MD), Dr. Hannawi obtained the fellowship of Royal College of Physicians of Edinburgh and completed her clinical training of Rheumatology in Australia. Dr. Hannawi proceeded with her academic attainment by obtaining a PhD in Rheumatology.
Her interest in the public health motivated her to proceed with getting a Master of International Public Health from University of Queensland, Australia, with Dean’s Commendation for High Achievement.
Dr. Hannawi has been awarded as best young investigator in Australia “Princess Alexandra” Research Week and awarded by the MOHAP for five consecutive years (2015, 2016, 2017, 2018 & 2019) for her research activities, scientific achievements and contribution. In 2017, Dr. Hannawi was chosen as one of the best 5 physicians in the federal health institutes for the Prime Minister Medal.
Dr. Hannawi has published in number of journals and has presented at different national and international conferences. Dr. Hannawi is a reviewer for many international rheumatology journals and a member of the Scientific Accreditation Organization of the MOHAP.
Khalid Alnaqbi is a Consultant and Head of Rheumatology and Immunology, at Al Ain Hospital, UAE. He graduated from the College of Medicine and Health Sciences, UAE University. He completed his post-graduate residency training at the University of Toronto in Internal Medicine and Rheumatology and then undertook a fellowship at the Spondyloarthritis Program. He holds multiple board certifications in Internal Medicine and Rheumatology (American Board of Internal Medicine, and Royal College of Physicians and Surgeons of Canada, RCPSC).
Dr. Alnaqbi pursued his academic interests by completing the Clinician Investigator Program with a thesis-based Master of Science (MSc). The thesis was on development of a new instrument to detect spondyloarthritis in patients with inflammatory bowel disease. He has published in peer-reviewed journals. He is a journal reviewer in prestigious journals. He wrote a book chapter on (Diagnosis of Ankylosing Spondylitis) in a book (Advances in the Management of Ankylosing Spondylitis).
He is a Fellow of the American College of Physicians (FACP), a Fellow of the American College of Rheumatology (FACR), and a Fellow of the RCPSC (FRCPC). He is a member in the Assessment of Spondyloarthritis international Society (ASAS), and the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA). He has been a speaker in numerous national and international meetings.
Dr. Alnaqbi established 4 specialized clinics in Al Ain Hospital: Early Arthritis Clinic, Connective Tissue Disease Clinic, Spondyloarthritis Clinic (the first in the Gulf), and Rheumatology Nurse Clinic in addition to the General Rheumatology Clinics.
He currently also acts as the Vice President of Emirates Society for Rheumatology, Rheumatology Program Leader in Al Ain Hospital for Clinical Care Programs (CCPC) which received the first accreditation by the Joint Commission International (JCI) outside the USA, Chair of Pharmaceutical & Therapeutic Committee of Al Ain Hospital, examiner for the Arab Board of Internal Medicine, and faculty of the Internal Medicine and Family Medicine residency programs in Al Ain.